Literature DB >> 2991965

Diazepam administration to mice prevents some of the changes in monoamine-mediated behaviour produced by repeated electroconvulsive shock treatment.

A R Green, J A Mountford.   

Abstract

Administration to mice of electroconvulsive shock (ECS) five times over 10 days results in an enhanced 5-HTP-induced head twitch response, an enhanced apomorphine-induced locomotor response and an attenuated sedation response to the alpha 2-adrenoceptor agonist clonidine. Diazepam (1.25 mg/kg IP) injected 5 min before each ECS abolished the enhanced 5-HT- and dopamine-mediated responses but left the attenuated sedation response unaltered. When diazepam was given 5 min after each convulsion it still had the same effect, although its effects on the ECS-induced changes was blocked by administration of the specific benzodiazepine antagonist Ro 15-1788 (10 mg/kg IP) at the same time as diazepam. It is concluded that diazepam can abolish the ECS-induced changes in 5-HT- and DA-mediated behaviour, but not alpha 2-adrenoceptor-mediated responses, possibly by interfering with post-ictal changes. The implications for administration of benzodiazepines during electroconvulsive therapy (ECT) are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991965     DOI: 10.1007/bf00431707

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  29 in total

1.  Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs.

Authors:  J P Evans; D G Grahame-Smith; A R Green; A F Tordoff
Journal:  Br J Pharmacol       Date:  1976-02       Impact factor: 8.739

2.  Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding.

Authors:  S J Peroutka; S H Snyder
Journal:  Science       Date:  1980-10-03       Impact factor: 47.728

3.  Effect of single and repeated electroconvulsive shock on serotonergic system in rat brain--II. Behavioural studies.

Authors:  U Lebrecht; J Z Nowak
Journal:  Neuropharmacology       Date:  1980-11       Impact factor: 5.250

4.  Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain.

Authors:  K J Kellar; C S Cascio; J A Butler; R N Kurtzke
Journal:  Eur J Pharmacol       Date:  1981-02-19       Impact factor: 4.432

5.  Factors influencing seizure duration and number of seizures applied in unilateral electroconvulsive therapy. Anaesthetics and benzodiazepines.

Authors:  L S Strömgren; J Dahl; N Fjeldborg; A Thomsen
Journal:  Acta Psychiatr Scand       Date:  1980-08       Impact factor: 6.392

6.  5-HT2 receptor characteristics in frontal cortex and 5-HT2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice.

Authors:  G M Goodwin; A R Green; P Johnson
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

7.  Comparison of the effects of repeated electroconvulsive shock on alpha 2- and beta-adrenoceptors in different regions of rat brain.

Authors:  S C Stanford; D J Nutt
Journal:  Neuroscience       Date:  1982-07       Impact factor: 3.590

8.  Alpha 2-adrenoceptors mediate clonidine-induced sedation in the rat.

Authors:  G M Drew; A J Gower; A S Marriott
Journal:  Br J Pharmacol       Date:  1979-09       Impact factor: 8.739

9.  Enhancement of responsiveness of the central serotonergic system and serotonin-2 receptor density in rat frontal cortex by electroconvulsive treatment.

Authors:  J Vetulani; U Lebrecht; A Pilc
Journal:  Eur J Pharmacol       Date:  1981-11-19       Impact factor: 4.432

10.  A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine.

Authors:  S J CORNE; R W PICKERING; B T WARNER
Journal:  Br J Pharmacol Chemother       Date:  1963-02
View more
  1 in total

1.  MK-801 prevents the enhanced behavioural response to apomorphine elicited by repeated electroconvulsive treatment in mice.

Authors:  G G Nomikos; A A Mathé; J M Mathé; T H Svensson
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.